Skip to main content

Free Content Multidrug resistance in new tuberculosis patients: burden and implications [Short communication]

Download Article:
(PDF 278.7 kb)
In 2010, 30 countries with anti-tuberculosis drug resistance surveillance data were each estimated to have more than 700 multidrug-resistant tuberculosis (MDR-TB) cases among their notified TB cases. New TB patients comprised a median of 54% (interquartile range 45–67) of the MDR-TB cases. The occurrence of MDR-TB in a new TB patient is a warning sign that MDR-TB is spreading in a community. While MDR-TB case-finding efforts should first prioritize previously treated patients, reaching universal access requires rapidly adding other risk groups, and then all new TB patients. Epidemiological data as presented in this paper can help inform country scale-up plans.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: case finding; drug susceptibility testing; tuberculosis; universal access

Document Type: Research Article

Affiliations: 1: University of California, San Francisco, California, USA 2: Stop TB Department, World Health Organization, Geneva, Switzerland 3: Western Pacific Regional Office, World Health Organization, Manila, The Philippines 4: European Regional Office, World Health Organization, Copenhagen, Denmark 5: South East Asia Regional Office, World Health Organization, New Delhi, India 6: Program for Appropriate Technology in Health, Seattle, WA, USA

Publication date: 01 April 2013

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

    Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more